Modern seeks approval of COVID-19 accelerator for all adults

Drug manufacturer Modern says it has asked the Food and Drug Administration to approve its COVID-19 boost for all adults, hoping not to be left behind as regulators prepare to offer a third dose of the Pfizer-BioNTech vaccine to anyone over 18 years of age.

In a brief statement, the Massachusetts company noted that the FDA had previously approved its acceleration – which is 50 micrograms of message RNA, or half the dose used in each of the initial shots – for the elderly, people who have a high risk of disease or work en. dangerous settings.

“The Modern COVID 19-boost vaccine is licensed for adults 18 years of age and older regardless of occupational risk factors in many international markets,” the company said Wednesday.

The Pfizer accelerator is subject to similar qualification rules as the Modern shot, but the FDA is ready to extend qualification to all adults immediately on Thursday. The Centers for Disease Control and Prevention will discuss the acceleration on Friday, clearing the way for a wide-ranging launch.

People who have received the one-shot Johnson & Johnson vaccine are eligible for a booster shot of any vaccine if they received their J&J dose at least two months ago.

Many states have been frustrated by the mix of qualifying rules and have encouraged people to go out and seek acceleration if they want, a remarkable end around the federal process.

Yet there was little to stand in their way. Pharmacies generally rely on self-certification to give the shots and Biden’s management has openly pressed for widespread boosts, citing data that suggests the extra doses replenish declining immunity and may help prevent a winter hike.

About 31 million Americans, or 16% of those fully vaccinated, have sought a boost so far, according to federal data.

Leave a Comment